1 – 43 of 43
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Long-term outcomes of vedolizumab in inflammatory bowel disease : the Swedish prospective multicentre SVEAH extension study
(
- Contribution to journal › Article
-
Mark
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE) : a multicentre, open-label, randomised controlled trial
(
- Contribution to journal › Article
- 2021
-
Mark
Clinical effectiveness of golimumab in ulcerative colitis : a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG
(
- Contribution to journal › Article
-
Mark
Real-world effectiveness of vedolizumab in inflammatory bowel disease : week 52 results from the Swedish prospective multicentre SVEAH study
(
- Contribution to journal › Article
- 2020
-
Mark
Short and long-term efficacy of adalimumab in ulcerative colitis : a real-life study
(
- Contribution to journal › Article
- 2019
-
Mark
The Cost-effectiveness of Biological Therapy Cycles in the Management of Crohn's Disease
(
- Contribution to journal › Article
-
Mark
Alkaliskt sfingomyelinas, en antiinflamatorisk faktor som kan motverka colit och colorektal cancer
(
- Contribution to journal › Published meeting abstract
- 2018
-
Mark
Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease
(
- Contribution to journal › Article
- 2017
-
Mark
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis
(
- Contribution to journal › Article
-
Mark
Long-term effectiveness of vedolizumab in inflammatory bowel disease : a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)
(
- Contribution to journal › Article
- 2016
-
Mark
Introduktion av biosimilarer kräver noggrann övervakning.
(
- Contribution to journal › Article
-
Mark
Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial.
(
- Contribution to journal › Article
- 2015
-
Mark
Enhanced colonic tumorigenesis in alkaline sphingomyelinase (NPP7) knockout mice.
(
- Contribution to journal › Article
- 2014
-
Mark
Changes of activity and isoforms of alkaline sphingomyelinase (nucleotide pyrophosphatase phosphodiesterase 7) in bile from patients undergoing endoscopic retrograde cholangiopancreatography.
(
- Contribution to journal › Article
-
Mark
Alkaline sphingomyelinase (NPP7) promotes cholesterol absorption by affecting sphingomyelin levels in the gut. A study with NPP7 knockout mice.
(
- Contribution to journal › Article
- 2013
-
Mark
Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients
(
- Contribution to journal › Article
- 2012
-
Mark
Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: A retrospective observational study
(
- Contribution to journal › Article
- 2011
-
Mark
Thrombotic occlusion of all left coronary branches in a young woman with severe ulcerative colitis
2011) In ISRN Cardiology(
- Contribution to journal › Letter
- 2010
-
Mark
Characterization of a novel sequence variant, TPMT*28, in the human thiopurine methyltransferase gene
(
- Contribution to journal › Article
-
Mark
Sphingolipids in human ileostomy content after meals containing milk sphingomyelin.
(
- Contribution to journal › Article
-
Mark
Clinical trial: colectomy after rescue therapy in ulcerative colitis-3-year follow-up of the Swedish-Danish controlled infliximab study
(
- Contribution to journal › Article
- 2009
-
Mark
Kolitcancer - mer myt än verklighet?
(
- Contribution to journal › Article
- 2007
-
Mark
Identification of aberrant forms of alkaline sphingomyelinase (NPP7) associated with human liver tumorigenesis.
(
- Contribution to journal › Article
- 2006
-
Mark
Can we prevent cancer using current drugs?
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2005
-
Mark
Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: A randomized, placebo-controlled study
(
- Contribution to journal › Article
- 2004
-
Mark
Helicobacter species in human colon biopsies
(
- Contribution to journal › Letter
-
Mark
Identification of two novel sequence variants affecting thiopurine methyltransferase enzyme activity.
(
- Contribution to journal › Article
-
Mark
Bioavailability of selenium from bovine milk as assessed in subjects with ileostomy
(
- Contribution to journal › Article
- 2003
-
Mark
Digestion and absorption of sphingolipids in food.
2003) p.70-70(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Purified intestinal alkaline sphingomyelinase inhibits proliferation without inducing apoptosis in HT-29 colon carcinoma cells.
(
- Contribution to journal › Article
-
Mark
Reduction in alkaline sphingomyelinase in colorectal tumorigenesis is not related to the APC gene mutation.
(
- Contribution to journal › Article
-
Mark
Sporadiska kolorektala polyper. Uppdaterade riktlinjer for endoskopikontroller
(
- Contribution to journal › Article
-
Mark
Purification, localization, and expression of human intestinal alkaline sphingomyelinase
(
- Contribution to journal › Article
- 2002
-
Mark
Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activity
(
- Contribution to journal › Article
- 2001
-
Mark
Familial occurrence of microscopic colitis: a report on five families
(
- Contribution to journal › Article
- 2000
-
Mark
Alkaline Sphingomyelinase; A Potential Inhibitor in Colorectal Carcinogenesis
2000)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Activation of neutral sphingomyelinase participates in ethanol-induced apoptosis in Hep G2 cells
(
- Contribution to journal › Article
- 1999
-
Mark
Familial adenomatous polyposis is associated with a marked decrease in alkaline sphingomyelinase activity: a key factor to the unrestrained cell proliferation?
(
- Contribution to journal › Article
- 1997
-
Mark
Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma
(
- Contribution to journal › Article
- 1996
-
Mark
Distribution of alkaline sphingomyelinase activity in human beings and animals. Tissue and species differences
(
- Contribution to journal › Article
- 1995
-
Mark
Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role
(
- Contribution to journal › Article
- 1994
-
Mark
The Expression of Glutathione Transferase μ in Patients with Inflammatory Bowel Disease
(
- Contribution to journal › Article
- 1992
-
Mark
Myasthenia gravis hos patienter med ulcerös kolit en förbisedd autoimmun association?
(
- Contribution to journal › Article